IMGO Insider Trading Activity and SEC Form 4 Filings
IMGO insider trading summary
No open-market insider purchases or sales of Imago BioSciences, Inc. (IMGO) have been reported on SEC Form 4 in the past 12 months.
Latest IMGO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 27, 2022 | Laura G. Eichorn | Chief Financial Officer | Sell | $111K (3,100 @ $35.93) |
| Dec 27, 2022 | Michael Arenberg | See Remarks | Sell | $2.5M (70,508 @ $35.93) |
| Dec 16, 2022 | Hugh Rienhoff JR | Chief Executive Officer | Sell | $9.5M (266,784 @ $35.78) |
| Dec 16, 2022 | Michael Arenberg | See Remarks | Sell | $1.7M (47,750 @ $35.78) |
| Dec 16, 2022 | Amy E. Tapper | See Remarks | Sell | $3.6M (100,302 @ $35.78) |
| Dec 15, 2022 | Jennifer Peppe | See Remarks | Sell | $4.3M (119,422 @ $35.80) |
| Dec 15, 2022 | Jennifer Peppe | See Remarks | Sell | $4.3M (119,422 @ $35.80) |
| Dec 15, 2022 | Laura G. Eichorn | Chief Financial Officer | Sell | $4.5M (126,714 @ $35.79) |
| Dec 15, 2022 | Hugh Rienhoff JR | Chief Executive Officer | Sell | $7.4M (206,309 @ $35.80) |
| Nov 2, 2022 | Amy E. Tapper | See Remarks | Sell | $13K (750 @ $17.90) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.